Patents by Inventor Dany Salvail

Dany Salvail has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12617809
    Abstract: The present invention includes a method of reducing or eliminating a cardiotoxic or cardiopathic effect of one or more active agents comprising: administering to a subject in need thereof an effective amount of one or more lipids that reduce or eliminate the cardiotoxic effect of the one or more active agents, wherein the lipid has formula:
    Type: Grant
    Filed: September 22, 2022
    Date of Patent: May 5, 2026
    Assignee: Signpath Pharma, Inc.
    Inventors: James McChesney, Annie Bouchard, Saravanan Kappusamy, John Kallikat Augustine, Daniel Emil Levy, Dany Salvail
  • Publication number: 20230042703
    Abstract: The present invention includes a method of reducing or eliminating a cardiotoxic or cardiopathic effect of one or more active agents comprising: administering to a subject in need thereof an effective amount of one or more lipids that reduce or eliminate the cardiotoxic effect of the one or more active agents, wherein the lipid has formula: .
    Type: Application
    Filed: September 22, 2022
    Publication date: February 9, 2023
    Inventors: James McChesney, Annie Bouchard, Saravanan Kappusamy, John Kallikat Augustine, Daniel Emil Levy, Dany Salvail